# COVID - Spplement VACCINE ADJ DISCOVERY PROGRAM (VADP)

> **NIH NIH N01** · UNIVERSITY OF MONTANA · 2020 · $3,699,711

## Abstract

To identify the optimal adjuvant for recombinant SARS-CoV2 vaccines, and to identify correlates of protection against SARS-CoV2 infection or disease, experimental SARS-CoV2 vaccines will be formulated with a panel of different vaccine adjuvants and tested side-by-side for immunogenicity and efficacy.

## Key facts

- **NIH application ID:** 10301500
- **Project number:** 75N93019C00045-P00003-9999-2
- **Recipient organization:** UNIVERSITY OF MONTANA
- **Principal Investigator:** JAY EVANS
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $3,699,711
- **Award type:** —
- **Project period:** 2019-09-30 → 2020-09-29

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10301500

## Citation

> US National Institutes of Health, RePORTER application 10301500, COVID - Spplement VACCINE ADJ DISCOVERY PROGRAM (VADP) (75N93019C00045-P00003-9999-2). Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/grant/nih/10301500. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*